盤後交易 19:00 (美東)241.890USD+0.460+0.19%關鍵數據
239.630今開
244.330最高
274.25K成交量
26.25本益比TTM
20.07本益比動
3.260股利TTM
0.25%換手率
243.280昨收
239.630最低
66.39M成交額
30.81本益比靜
3.55市淨率
1.35%股息率 TTM
6.62%ROA
247.91852週最高
94.49量比
866.00M淨利潤
110.37M總股本
9.2097每股盈餘TTM
0.66Beta
14.27%ROE
168.34952週最低
8.13%振幅
32.12%毛利率
26.70B總市值
9.51回報/風險
1.51%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Quest Diagnostics Inc評分
-0.20與上次評分對比預測7.58
財務診斷8.41
技術分析3.04
公司估值8.96
機構認同度10.00
風險評估9.84
分析師評級
買入評級
246.023目標均價
+4.69%漲幅空間
Quest Diagnostics Inc 最新財報電話會記錄
奎斯特診斷 (DGX) 2026 年第三季財報電話會議:營收成長 10%,上調財測指引
奎斯特診斷(Quest Diagnostics)2026 年第三季財報電話會議:營收成長 10% 至 31 億美元,調整後每股盈餘成長 15.4%,並調升 2026 財年財測指引。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Quest Diagnostics Inc 簡介
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
行業醫療服務供應商
公司代碼DGX
員工數量45000
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Vanguard Capital Management, LLC | 6.46% |
|---|
| BlackRock Institutional Trust Company, N.A. | 5.58% |
|---|
| T. Rowe Price Associates, Inc. | 5.54% |
|---|
| Vanguard Portfolio Management, LLC | 5.49% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 56.33% |
|---|
| Investment Advisor/Hedge Fund | 29.68% |
|---|
| Research Firm | 5.13% |
|---|
| Pension Fund | 2.82% |
|---|
常見問題
Quest Diagnostics Inc(DGX)的當前股價是多少?
Quest Diagnostics Inc(DGX)的當前股價是 241.89。
Quest Diagnostics Inc 的股票代碼是什麼?
Quest Diagnostics Inc的股票代碼是DGX。
Quest Diagnostics Inc股票的52週最高點是多少?
Quest Diagnostics Inc股票的52週最高點是247.92。
Quest Diagnostics Inc股票的52週最低點是多少?
Quest Diagnostics Inc股票的52週最低點是168.35。
Quest Diagnostics Inc的市值是多少?
Quest Diagnostics Inc的市值是26.70B。
現在Quest Diagnostics Inc(DGX)的股票是買入、持有還是賣出?
根據分析師評級,Quest Diagnostics Inc(DGX)的總體評級為買入,目標價格為246.02。
Quest Diagnostics Inc(DGX)股票的每股收益(EPS TTM)是多少
Quest Diagnostics Inc(DGX)股票的每股收益(EPS TTM)是9.21。